253 related articles for article (PubMed ID: 11173059)
1. Pharmacogenomics of neurodegenerative diseases.
Maimone D; Dominici R; Grimaldi LM
Eur J Pharmacol; 2001 Feb; 413(1):11-29. PubMed ID: 11173059
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
3. Genes and the environment in neurodegeneration.
Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol: A Focus on Several Neurodegenerative Diseases.
Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
[TBL] [Abstract][Full Text] [Related]
5. [Neurodegenerative disorders: the role of genetic factors in their origin and the efficiency of treatment].
Sukhanov VA; Ionov ID; Piruzian LA
Fiziol Cheloveka; 2005; 31(4):119-30. PubMed ID: 16122046
[No Abstract] [Full Text] [Related]
6. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
Gaggelli E; Kozlowski H; Valensin D; Valensin G
Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
[No Abstract] [Full Text] [Related]
7. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
8. Gene discovery and validation for neurodegenerative diseases.
Mathisen PM
Drug Discov Today; 2003 Jan; 8(1):39-46. PubMed ID: 12546990
[TBL] [Abstract][Full Text] [Related]
9. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
van Muiswinkel FL; Kuiperij HB
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
[TBL] [Abstract][Full Text] [Related]
10. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
Fang M; Liu Y; Huang C; Fan S
Biofactors; 2024; 50(3):422-438. PubMed ID: 37966813
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA damage and repair in neurodegenerative disorders.
Yang JL; Weissman L; Bohr VA; Mattson MP
DNA Repair (Amst); 2008 Jul; 7(7):1110-20. PubMed ID: 18463003
[TBL] [Abstract][Full Text] [Related]
12. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
Dhib-Jalbut S; Arnold DL; Cleveland DW; Fisher M; Friedlander RM; Mouradian MM; Przedborski S; Trapp BD; Wyss-Coray T; Yong VW
J Neuroimmunol; 2006 Jul; 176(1-2):198-215. PubMed ID: 16983747
[TBL] [Abstract][Full Text] [Related]
13. Targeting programmed cell death in neurodegenerative diseases.
Vila M; Przedborski S
Nat Rev Neurosci; 2003 May; 4(5):365-75. PubMed ID: 12728264
[No Abstract] [Full Text] [Related]
14. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
[TBL] [Abstract][Full Text] [Related]
15. Toxic proteins in neurodegenerative disease.
Taylor JP; Hardy J; Fischbeck KH
Science; 2002 Jun; 296(5575):1991-5. PubMed ID: 12065827
[TBL] [Abstract][Full Text] [Related]
16. Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases.
Moloudizargari M; Asghari MH; Ghobadi E; Fallah M; Rasouli S; Abdollahi M
Ageing Res Rev; 2017 Nov; 40():64-74. PubMed ID: 28923312
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
18. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
Barnham KJ; Bush AI
Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
[TBL] [Abstract][Full Text] [Related]
19. [Clinical pharmacology and therapeutic aspects in certain degenerative neurological diseases].
Maloteaux JM
Bull Mem Acad R Med Belg; 1996; 151(10-11):429-32; discussion 432-4. PubMed ID: 9491620
[TBL] [Abstract][Full Text] [Related]
20. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
